Table 2.
Summary Statistics for Younger Women With or Without Breast Cancer Aged 18–44 Years, Active Treatment Subsample, 2006
| Variable | Women with breast cancer (active treatment) |
Women with breast cancer (not on active treatment) |
Women without breast cancer (after matching to active treatment group) |
p-value for differences (BC versus matched controls) |
|---|---|---|---|---|
| Observations (n) | 3,065 | 6,847 | 3,065 | |
| Costs ($; M [SE])a | ||||
| Annualized total costs | 68,096 (1,077) | 10,026 (174) | 6,019 (314) | <0.01 |
| Annualized outpatient costs | 64,271 (1,029) | 8,377 (163) | 4,820 (286) | <0.01 |
| Annualized inpatient costs | 140 (18) | 77 (13) | 39 (8) | <0.01 |
| Annualized prescription drug costs | 3,685 (196) | 1,573 (37) | 1,161 (69) | <0.01 |
| Age (years) | 0.83 | |||
| 18–23 | 0.2 | 0.7 | 0.2 | |
| 24–28 | 1.3 | 6.9 | 1.2 | |
| 29–33 | 6.4 | 13.9 | 6.6 | |
| 34–38 | 22.3 | 21.2 | 21.2 | |
| 39–44 | 69.8 | 57.4 | 70.8 | |
| Employment | 0.73 | |||
| Employed, full-time | 69.6 | 71.7 | 70.2 | |
| Employed, part-time | 1.7 | 1.5 | 1.4 | |
| Charlson Indexb | 0.85 | |||
| Charlson score of zero | 86.3 | 90.0 | 86.2 | |
| Charlson score of one | 11.6 | 8.6 | 11.9 | |
| Charlson score greater than one | 2.1 | 1.4 | 1.9 | |
| Comorbidities in 2006 | ||||
| Ovarian cancer | 1.0 | 0.5 | 0.8 | 0.37 |
| Colorectal cancer | 0.7 | 0.1 | 0.7 | 0.94 |
| Lung cancer | 2.1 | 0.3 | 2.0 | 0.75 |
| Cervical cancer | 0.6 | 0.3 | 0.5 | 0.76 |
| Skin cancer | 2.7 | 1.2 | 2.6 | 0.81 |
| Leukemia and lymphoma | 1.6 | 0.4 | 1.5 | 0.80 |
| Hypertension | 10.4 | 7.1 | 10.6 | 0.87 |
| Dyslipidemia | 8.8 | 8.8 | 9.6 | 0.31 |
| Pneumonia | 2.1 | 0.9 | 2.5 | 0.34 |
| Asthma | 2.6 | 2.9 | 2.4 | 0.54 |
| Depression | 6.0 | 4.9 | 6.8 | 0.25 |
| Back problems | 17.0 | 15.0 | 17.3 | 0.74 |
| Skin disorders | 22.5 | 19.3 | 23.3 | 0.48 |
| Injuries | 31.7 | 19.0 | 32.5 | 0.52 |
| Pregnancy | 3.6 | 15.5 | 3.5 | 0.90 |
| Arthritis | 15.9 | 12.5 | 16.9 | 0.33 |
| Mental health/substance abuse | 15.1 | 11.0 | 15.8 | 0.41 |
Note: Values are percentages unless otherwise noted. Summary statistics are presented for younger women with breast cancer and propensity score–matched comparison sample.
Boldface indicates a statistically significant difference from the breast cancer sample (p < 0.05).
State indicator variables were included in the match; none were significantly different than the breast cancer sample at the 5% level.
a
All costs are per capita and were adjusted to 2012 U.S. dollars.
b
This Charlson Index excludes cancers.
BC, breast cancer